Against the proposition: All patients with advanced HIV disease should be offered rifabutin prophylaxis

Genitourinary Medicine

Volumn 72, Issue 4, 1996, Pages 269-271

  Pozniak, A ^a   Nelson, M R ^b  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; RIFABUTIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; PRIORITY JOURNAL; SHORT SURVEY;

EID: 79960430709     PISSN: 02664348     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.72.4.269     Document Type: Short Survey

References (22)

1. Yajko DM, Chin DP, Gonzalez PC, Nassos PS, Hopewell PC, Reingold AL, et al. Mycobacterium avium complex in water, food and soil samples collected from the environment of HIV infected individuals. J Acquired Imm Defic Syndr 1995;9:176-82.
2. Maslow JM, Barber TW, Falkinham JO, Arbeit RD. Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. Lancet 1994;343:1137-41.
3. Arbeit RD, Slutsky A, Barber TW, Maslow JN, Niemczyk S, Falkinham JO, et al. Genetic diversity among strains of Mycobacterium avium causing monoclonal and polyclonal bacteraemia in patients with AIDS. J Infect Dis 1993;167:1384-90.
4. Nightingale SD, Cameron DW, Gordin FM, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993;329:828-33.
5. Ostroff SM, Speigle RA, Feinberg J, Benson CA, Horsberg CR. Preventing disseminated Mycobacterium avium complex disease in patients infected with human deficiency virus. Clin Infect Dis 1995;21(suppl 1):S72-6.
6. Bishai WR, Graham NMH, Harrington S, Page C, Moore-Rice K, Hooper N, Chaisson RE. N Engl J Med 1996;334:1573-6.
7. Moore RD, Chaisson RE. Survival analysis of two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex in AIDS. AIDS 1995;9:1337-42.
8. Young LS. Treatment and prophylaxis of Mycobacterium avium complex. Inter J STS AIDS 1996;7(suppl 1):23-27.
9. Havlik JA Jr, Horsburgh CR, Metchock B, Williams PP, Fann A, Thompson SE, et al. Disseminated Mycobacterium avium complex infection; clinical identification and epidemiologic trends. J Infect Dis 1992;165:577-80.
10. Horsburgh CR. Mycobacterium avium complex infection in AIDS. N Engl J Med 1991;324:1332-8.
11. Nightingale SD, Byrd LT, Southern PM, Jockrusch JD, Cal CX, Wynne BA. Incidence of Mycobacterium avium-intracellulare complex bacteraemia in human immunodeficiency virus-positive patients. J Infect Dis 1992;165:1082-5.
12. Chin DP, Reingold AL, Stone EN, Vittinghoff E, Horsburgh R, Simon EM, et al. The impact of Mycobacterium avium complex bacteraemia and its treatment on survival of AIDS patients - a prospective study. J Infect Dis 1994;170:578-84.
13. Horsburgh CR Jr, Harlik JA, Ellis DA, Kennedy E, Fann SA, Dubois RE, et al. Survival of patients with acquired immune deficiency syndrome and disseminated Mycobacterium avium complex infection with and without antimycobacterial chemotherapy. Am Rev Resp Dis 1991;144:557-9.
14. Macher AM, Kovacs JA, Gill V, Roberts SD, Ames J, Park CH, et al. Bacteraemia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome. Ann Intern Med 1983;99:782-85.
15. Reichert CM, O'Leary TJ, Levens DL, Simrell CR, Macher AM. Autopsy pathology in the acquired immunodeficiency syndrome. Am J Pathol 1983;112:357-82.
16. Inderlied CB, Kemper CA, Bermudez LEM. The Mycobacterium avium complex. Clin Microbiol Rev 1993;6:266-310.
17. Inwald D, Nelson M, Cramp M, Francis N, Gazzard B. Cutaneous manifestations of mycobacterial infection in patients with AIDS. Br J Dermatol 1994;130:111-4.
18. Nightingale SD, Cameron DW, Gordin FM, Sullan PM, Cohn DL, Chaisson RE, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993;329:828-33.
19. Moore RD, Chaisson RE. Survival analysis of two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex in AIDS. AIDS 1995;9:1337-42.
20. Pierce M, Crampton S, Henry D, Craft C, Nortario G. The effect of MAC and its Prevention on Survival in Patient with Advanced HIV Infection. In Abstracts of ICAAC 1995; San Francisco, USA.
21. Havllir DV, McCutchan JA, Bozzette SA, Dunne M. A double blind randomised study of weekly azithromycin and rifabutin for the prevention of Mycobacterium avium complex (MAC) in AIDS patients. Abstract 204; In: Abstracts of the 3rd Conference on Retroviruses and Opportunistic Infection, Washing 1996.
22. Simpson RN, Lavallee RL, Revicki DJ. Outcome and costs of short and long term rifabutin prophylaxis for Mycobacterium avium (MAC) disease in AIDS patients in the United Kingdom. AIDS 1994;8(54) Abstract 18.5.